5 terminated, 1 unknown. 6 Phase 3.
By phase and status
Follow paclitaxel poliglumex: new trials by email Literature Review of paclitaxel poliglumex trials Research Report on paclitaxel poliglumex
Trials (filtered) newest first · largest first
All 6 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
carboplatin, paclitaxel, paclitaxel poliglumex - Lung Cancer | Phase 3 | Terminated | CTI BioPharma | 450 | 2007-08-01 | 2020-10-05 |
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
paclitaxel, paclitaxel poliglumex - NSCLC | Phase 3 | Terminated | CTI BioPharma | 600 | 2005-12-01 | 2020-11-24 |
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
Clinical Observation, Laboratory Biomarker Analysis, Paclitaxel - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Unknown | GOG Foundation | 1157 | 2005-03-21 | 2021-09-30 |
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
carboplatin, paclitaxel, paclitaxel poliglumex - Lung Cancer | Phase 3 | Terminated | CTI BioPharma | | 2003-01-01 | 2020-10-05 |
Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
gemcitabine hydrochloride, paclitaxel poliglumex, vinorelbine tartrate - Lung Cancer | Phase 3 | Terminated | CTI BioPharma | | 2003-01-01 | 2020-10-05 |
Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
docetaxel, paclitaxel poliglumex - Lung Cancer | Phase 3 | Terminated | CTI BioPharma | 350 | 2003-01-01 | 2020-10-05 |
Conditions studied
Carcinoma, Non-Small-Cell Lung (5) · Lung Neoplasms (4) · Brenner Tumor (1) · Fallopian Tube Neoplasms (1)
Sponsors
CTI BioPharma (5) · GOG Foundation (1)
Countries
United States (6) · Canada (2) · Argentina (1) · Bulgaria (1) · Hungary (1) · Mexico (1) · Poland (1) · Romania (1) · Russia (1) · Ukraine (1) · United Kingdom (1)
Top investigators
Brenda Garrison (1) · Fred B. Oldham, MD (1) · Larry J Copeland (1) · Meghann Smith (1) · Melinda Bomar (1)
Results publications
PMID 18520802, PMID 18594318, PMID 35759733
NIH funding
U10CA027469 (1), U10CA180868 (1)